Cardinal Health, Inc. $CAH Stake Raised by Rakuten Investment Management Inc.

Rakuten Investment Management Inc. increased its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 9.1% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 41,851 shares of the company’s stock after buying an additional 3,480 shares during the quarter. Rakuten Investment Management Inc.’s holdings in Cardinal Health were worth $9,371,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in CAH. Provenance Wealth Advisors LLC lifted its position in Cardinal Health by 1,940.0% in the third quarter. Provenance Wealth Advisors LLC now owns 408 shares of the company’s stock worth $91,000 after purchasing an additional 388 shares during the period. First Nebraska Trust Co bought a new stake in Cardinal Health in the 3rd quarter valued at $18,218,000. Next Level Wealth Planning LLC bought a new stake in Cardinal Health in the 3rd quarter valued at $44,000. Signature Equity Partners LLC increased its holdings in Cardinal Health by 3.8% in the 3rd quarter. Signature Equity Partners LLC now owns 1,335 shares of the company’s stock valued at $297,000 after buying an additional 49 shares during the period. Finally, TSG Advice Partners LLC acquired a new position in shares of Cardinal Health in the 3rd quarter valued at $3,279,000. 87.17% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities analysts have recently commented on CAH shares. UBS Group raised their price objective on shares of Cardinal Health from $280.00 to $295.00 and gave the stock a “buy” rating in a report on Friday, October 16th. Mizuho set a $290.00 target price on shares of Cardinal Health in a research report on Thursday. Royal Bank Of Canada began coverage on shares of Cardinal Health in a research note on Wednesday, August 19th. They issued an “outperform” rating and a $276.00 target price on the stock. Citigroup increased their price target on shares of Cardinal Health from $265.00 to $280.00 and gave the stock a “buy” rating in a research report on Wednesday, August 12th. Finally, Wall Street Zen upgraded shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Sunday, October 25th. Sixteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $271.31.

Cardinal Health Price Performance

Shares of CAH stock opened at $268.10 on Friday. The stock’s fifty day simple moving average is $239.73 and its 200 day simple moving average is $223.24. The firm has a market cap of $62.08 billion, a price-to-earnings ratio of 37.08, a P/E/G ratio of 1.57 and a beta of 0.53. Cardinal Health, Inc. has a one year low of $180.45 and a one year high of $286.29.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Thursday, November 5th. The company reported $3.26 earnings per share for the quarter, beating analysts’ consensus estimates of $2.94 by $0.32. Cardinal Health had a negative return on equity of 98.53% and a net margin of 0.67%. The firm had revenue of $67.51 billion for the quarter, compared to analysts’ expectations of $66.67 billion. During the same period in the prior year, the business posted $2.55 earnings per share. The business’s revenue was up 5.5% compared to the same quarter last year. On average, research analysts anticipate that Cardinal Health, Inc. will post 12.55 earnings per share for the current year.

Cardinal Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, October 15th. Stockholders of record on Thursday, October 1st were issued a $0.5158 dividend. The ex-dividend date of this dividend was Thursday, October 1st. This represents a $2.06 annualized dividend and a dividend yield of 0.8%. Cardinal Health’s dividend payout ratio is presently 28.49%.

Insider Buying and Selling at Cardinal Health

In other Cardinal Health news, insider Jessica L. Mayer sold 29,436 shares of the business’s stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $236.19, for a total value of $6,952,488.84. Following the transaction, the insider directly owned 33,076 shares in the company, valued at $7,812,220.44. The trade was a 47.09% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Jason M. Hollar sold 44,529 shares of the business’s stock in a transaction dated Wednesday, August 19th. The shares were sold at an average price of $236.18, for a total transaction of $10,516,859.22. Following the completion of the transaction, the chief executive officer owned 190,603 shares in the company, valued at approximately $45,016,616.54. This trade represents a 18.94% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 210,271 shares of company stock worth $49,626,657 over the last ninety days. Company insiders own 0.12% of the company’s stock.

Cardinal Health News Summary

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Adjusted EPS was $3.26, above the roughly $2.94 analyst consensus and up 28% year over year. Revenue rose 5% to $67.5 billion, also topping expectations. Cardinal Health Q1 results and outlook
• Positive Sentiment: Management raised fiscal 2027 adjusted EPS guidance to $12.80–$13.00, signaling confidence in continued growth. Robust pharmaceutical sales helped drive the quarter. Q1 earnings beat on pharmaceutical strength
• Positive Sentiment: Cardinal completed a $500 million share-repurchase program during the quarter. The results also drew favorable analyst attention, including a price-target increase. Analyst raises price target
• Neutral Sentiment: The shares also advanced while the broader market was under pressure, suggesting the earnings and guidance news were a company-specific catalyst. Cardinal gains amid broader market declines
• Negative Sentiment: Management noted modest commodity and petroleum-related pressure in medical distribution, a potential headwind against otherwise healthy demand. Demand and commodity pressures

Cardinal Health Profile

Cardinal Health, Inc is a healthcare services and products company that supports the distribution and delivery of pharmaceuticals, medical products and related services. The company serves hospitals, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers.

Its Pharmaceutical and Specialty Solutions segment distributes branded, generic and specialty pharmaceuticals, as well as consumer health products, to pharmacies and healthcare institutions.